Belumosudil
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Belumosudil, covering 2021-09-13 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease [Phase 2]